- €149.18m
- €177.96m
- €192.47m
- 96
- 77
- 63
- 94
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | ARS | ARS | ARS | ARS | ARS |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 146 | 114 | 139 | 171 | 192 |
Cost of Revenue | |||||
Gross Profit | 75.4 | 62.4 | 72.2 | 82.7 | 95.4 |
Selling / General / Administrative Expenses | |||||
Depreciation and Amortization | |||||
Unusual Expense / Income | |||||
Other Operating Expenses | |||||
Total Operating Expenses | 126 | 104 | 122 | 150 | 169 |
Operating Profit | 19.4 | 10.2 | 16.8 | 20.8 | 23.1 |
Total Net Non Operating Interest Income / Expense | |||||
Net Income Before Taxes | 19.1 | 9.65 | 16.7 | 19.8 | 22.9 |
Provision for Income Taxes | |||||
Net Income After Taxes | 16.1 | 6.38 | 13 | 15 | 17.5 |
Minority Interest | |||||
Net Income Before Extraordinary Items | |||||
Net Income | 16.1 | 6.33 | 12.9 | 14.9 | 17.3 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | 16.1 | 6.33 | 12.9 | 14.9 | 17.3 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | 0.659 | 0.26 | 0.53 | 0.612 | 0.7 |
Dividends per Share |